‘Game-changing’ Alzheimer’s drug approved in US – as UK decision looms
A groundbreaking Alzheimer’s drug has been approved in the United States that slows mental decline by up to 60 percent. Donanemab, sold in the US under the brand name Kisunla, is available for patients with early symptoms of the disease. In Alzheimer’s disease, two proteins accumulate that cause brain cells to dieSource: AP The drug … Read more